Skip to main content
Log in

Adverse Drug Events as a Cause of Hospitalization in Older Adults

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Older adults are about four to seven times more likely than younger persons to experience adverse drug events (ADEs) that cause hospitalization, especially if they are women and take multiple medications. The prevalence of drug-related hospitalizations has been reported to be as high as 31%, with large heterogeneity between different studies, depending on study setting (all hospital admissions or only acute hospital admissions), study population (entire hospital, specific wards, selected population and/or age groups), type of drug-related problem measured (adverse drug reaction or ADE), method of data collection (chart review, spontaneous reporting or database research) and method and definition used to detect ADEs. The higher risk of drug-related hospitalizations in older adults is mainly caused by age-related pharmacokinetic and pharmacodynamic changes, a higher number of chronic conditions and polypharmacy, which is often associated with the use of potentially inappropriate drugs. Other factors that have been involved are errors related to prescription or administration of drugs, medication non-adherence and inadequate monitoring of pharmacological therapies. A few commonly used drugs are responsible for the majority of emergency hospitalizations in older subjects, i.e. warfarin, oral antiplatelet agents, insulin and oral hypoglycaemic agents, central nervous system agents.

The aims of the present review are to summarize recent evidence concerning drug-related hospitalization in older adults, to assess the contribution of specific medications, and to identify potential interventions able to reduce the occurrence of these drug-related events, as they are, at least partly, potentially preventable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 2004 May 18; 140 (10): 795–801

    PubMed  Google Scholar 

  2. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. London: European Agency for the Evaluation of Medical Products, Human Medicines Evaluation Unit; 1995._Available from URL: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC00002749.pdf [Accessed 2012, October 5]

  3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 Aug 4; 353 (5): 487–97

    Article  PubMed  CAS  Google Scholar 

  4. Rogers S, Wilson D, Wan S, et al. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging 2009; 26 (11): 951–61

    Article  PubMed  Google Scholar 

  5. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32 (1): 19–31

    Article  PubMed  CAS  Google Scholar 

  6. Beijer HJ, de Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002 Apr; 24 (2): 46–54

    Article  PubMed  CAS  Google Scholar 

  7. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008 Jul; 42 (7): 1017–25

    Article  PubMed  Google Scholar 

  8. Hakkarainen KM, Hedna K, Petzold M, et al. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions — a meta-analysis. PLoS One 2012; 7 (3): e33236

    Article  PubMed  CAS  Google Scholar 

  9. Leendertse AJ, Visser D, Egberts AC, et al. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf 2010 Mar; 33 (3): 233–44

    Article  PubMed  Google Scholar 

  10. Carrasco-Garrido P, de Andrés LA, Barrera VH, et al. Trends of adverse drug reactions related-hospitalizations in Spain (2001–2006). BMC Health Serv Res 2010 Oct 13; 10: 287

    Article  PubMed  CAS  Google Scholar 

  11. Schneeweiss S, Hasford J, Göttler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002 Jul; 58 (4): 285–91

    Article  PubMed  Google Scholar 

  12. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004 Jul 3; 329 (7456): 15–19

    Article  PubMed  Google Scholar 

  13. Wu TY, Jen MH, Bottle A, et al. Ten-years trends in hospital admissions for adverse drug reactions in England 1999–2009. J R Soc Med 2010 Jun; 103 (6): 239–50

    Article  PubMed  Google Scholar 

  14. Stausberg J, Hasford J. Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data. BMC Health Serv Res 2011 May 29; 11: 134

    Article  PubMed  Google Scholar 

  15. Mannesse CK, Derkx FH, de Ridder MA, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000 Jan; 29 (1): 35–9

    Article  PubMed  CAS  Google Scholar 

  16. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001 May–Jun; 31 (4): 199–205

    Article  PubMed  CAS  Google Scholar 

  17. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50 (12): 1962–8

    Article  PubMed  Google Scholar 

  18. Somers A, Robays H, Vander Stichele R, et al. Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging 2010 Jun; 14 (6): 477–82

    Article  PubMed  CAS  Google Scholar 

  19. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011 Nov 24; 365 (21): 2002–12

    Article  PubMed  CAS  Google Scholar 

  20. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 2012 Jan; 60 (1): 34–41

    Article  PubMed  Google Scholar 

  21. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006 Oct 18; 296 (15): 1858–66

    Article  PubMed  CAS  Google Scholar 

  22. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 2008 Nov; 19 (7): 505–10

    Article  PubMed  Google Scholar 

  23. Popplewell PY, Henschke PJ. Acute admissions to a geriatric assessment unit. Med J Aust 1982 Apr 17; 1 (8): 343–4

    PubMed  CAS  Google Scholar 

  24. Ruiter R, Visser LE, Rodenburg EM, et al. Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. Drugs Aging 2012 Mar 1; 29 (3): 225–32

    Article  PubMed  Google Scholar 

  25. Hartholt KA, van der Velde N, Looman CW, et al. Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981–2007: less rapid increase, different drugs. PLoS One 2010 Nov 12; 5 (11): e13977

    Article  PubMed  CAS  Google Scholar 

  26. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001 Mar–Apr; 41 (2): 192–9

    CAS  Google Scholar 

  27. Bustacchini S, Corsonello A, Onder G, et al. Pharmacoeconomics and aging. Drugs Aging 2009 Dec; 26 Suppl. 1: 75–87

    Article  PubMed  Google Scholar 

  28. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007 Feb; 63 (2): 136–47

    Article  PubMed  CAS  Google Scholar 

  29. Mjörndal T, Boman MD, Hägg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002 Jan–Feb; 11 (1): 65–72

    Google Scholar 

  30. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009; 26 (6): 475–82

    Article  PubMed  Google Scholar 

  31. Chen YC, Fan JS, Hsu TF, et al. Detection of patients presenting with adverse drug events in the emergency department. Intern Med J 2012 Jun; 42 (6): 651–7

    Article  PubMed  Google Scholar 

  32. Shehab N, Sperling LS, Kegler SR, et al. National estimates of emergency department visits for hemorrhagerelated adverse events from clopidogrel plus aspirin and from warfarin. Arch Intern Med 2010 Nov 22; 170 (21): 1926–33

    Article  PubMed  Google Scholar 

  33. Usman MH, Notaro LA, Nagarakanti R, et al. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble? Am J Cardiol 2009 Apr 15; 103 (8): 1107–12

    Article  PubMed  CAS  Google Scholar 

  34. Lane DA, Lip GY. Use of the CHA2DS2-VASc and HASBLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation 2012 Aug 14; 126 (7): 860–5

    Article  PubMed  Google Scholar 

  35. Connolly SJ, Ezekowitz MD, Yusuf S, et al., RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 Sep 17; 361 (12): 1139–51

    Article  PubMed  CAS  Google Scholar 

  36. Patel MR, Mahaffey KW, Garg J, et al., ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011 Sep 8; 365 (10): 883–91

    Article  PubMed  CAS  Google Scholar 

  37. Granger CB, Alexander JH, McMurray JJ, et al., ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011 Sep 15; 365 (11): 981–92

    Article  PubMed  CAS  Google Scholar 

  38. Miller CS, Grandi SM, Shimony A, et al. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 2012 Aug 1; 110 (3): 453–60

    Article  PubMed  CAS  Google Scholar 

  39. Connolly SJ, Eikelboom J, Joyner C, et al., AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011 Mar 3; 364 (9): 806–17

    Article  PubMed  CAS  Google Scholar 

  40. Garcia DA, Baglin TP, Weitz JI, et al., American College of Chest Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines. Chest 2012 Feb; 141 (2 Suppl.): e24S–e43S

    Article  PubMed  CAS  Google Scholar 

  41. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 Nov 16; 368 (9038): 1329–39

    Google Scholar 

  42. Ng FH, Wong SY, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003 Aug 15; 18 (4): 443–9

    Article  PubMed  CAS  Google Scholar 

  43. Serebruany VL, Malinin AI, Eisert RM, et al. Risk of bleeding complications with antiplatelet agents: metaanalysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol 2004 Jan; 75 (1): 40–7

    Article  PubMed  CAS  Google Scholar 

  44. Sudlow CL, Mason G, Maurice JB, et al. Thienopyridine derivates versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev 2009 Oct 7; 4: CD001246

    PubMed  Google Scholar 

  45. Wiviott SD, Braunwald E, McCabe CH, et al., TRITONTIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007 Nov 15; 357 (20): 2001–15

    Article  PubMed  CAS  Google Scholar 

  46. Wallentin L, Becker RC, Budaj A, et al., PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009 Sep 10; 361 (11): 1045–57

    Article  PubMed  CAS  Google Scholar 

  47. Almadi MA, Barkun A, Brophy J. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease [published erratum appears in JAMA 2012 Jan 11; 307 (2): 147]. JAMA 2011 Dec 7; 306 (21): 2367–74

    Article  PubMed  CAS  Google Scholar 

  48. DeEugenio D, Kolman L, DeCaro M, et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 2007 May; 27 (5): 691–6

    Article  PubMed  CAS  Google Scholar 

  49. Sørensen R, Hansen ML, Abildstrom SZ, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 2009 Dec 12; 374 (9706): 1967–74

    Article  PubMed  CAS  Google Scholar 

  50. Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 2010 Sep 13; 170 (16): 1433–41

    Article  PubMed  CAS  Google Scholar 

  51. Gao F, Zhou YJ, Wang ZJ, et al. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Int J Cardiol 2011 Apr 1; 148 (1): 96–101

    Article  PubMed  Google Scholar 

  52. Caballero L, Ruiz-Nodar JM, Marín F, et al. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting. Age Ageing (2013); 42 (1): 70–5

    Article  PubMed  Google Scholar 

  53. Pilotto A, Franceschi M, Maggi S, et al. Optimal management of peptic ulcer disease in the elderly. Drugs Aging 2010 Jul 1; 27 (7): 545–58

    Article  PubMed  CAS  Google Scholar 

  54. Kalyanasundaram A, Lincoff AM. Managing adverse effects and drug—drug interactions of antiplatelet agents. Nat Rev Cardiol 2011 Sep 13; 8 (10): 592–600

    Article  PubMed  CAS  Google Scholar 

  55. Wu WK, Pantaleo N. Evaluation of outpatients adverse drug reactions leading to hospitalization. Am J Health Syst Pharm 2003 Feb 1; 60 (3): 253–9

    PubMed  Google Scholar 

  56. Brvar M, Fokter N, Bunc M, et al. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009 May 4; 9: 8

    Article  PubMed  Google Scholar 

  57. Juurlink DN, Mamdani M, Kopp A, et al. Drug—drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003 Apr 2; 289 (13): 1652–8

    Article  PubMed  CAS  Google Scholar 

  58. Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 2009 Mar; 94 6(3): 741–5

    Google Scholar 

  59. Punthakee Z, Miller ME, Launer LJ, et al., ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012 Apr; 35 6(4): 787–93

    Article  Google Scholar 

  60. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009 Apr 15; 301 (15): 1565–72

    Article  PubMed  CAS  Google Scholar 

  61. Brito M, Ligthelm RJ, Boemi M, et al. Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: a consensus statement. Indian J Endocrinol Metab 2011 Jul; 15 (3): 152–60

    Article  PubMed  CAS  Google Scholar 

  62. Schejter YD, Turvall E, Ackerman Z. Characteristics of patients with sulphonurea-induced hypoglycemia. J Am Med Dir Assoc 2012 Mar; 13 (3): 234–8

    Article  PubMed  Google Scholar 

  63. Paolisso G, Monami M, Martella R, et al. Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks? Adv Ther 2012 Mar; 29 (3): 218–33

    Article  PubMed  CAS  Google Scholar 

  64. Guan Y, Hao C, Cha DR, et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005 Aug; 11 (8): 861–6

    Article  PubMed  CAS  Google Scholar 

  65. Stafylas PC, Sarafidis PA, Lasaridis AN. The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int J Cardiol 2009 Jan 24; 131 (3): 298–304

    Article  PubMed  Google Scholar 

  66. Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones: systematic review and metaanalysis of observational studies. BMJ 2011 Mar 17; 342: d1309

    Article  PubMed  CAS  Google Scholar 

  67. Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, et al., Dutch HARM-Wrestling Task Force. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf 2012 Mar 1; 35 (3): 245–59

    Article  PubMed  Google Scholar 

  68. Yang IA, Clarke MS, Sim EH, et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012 Jul 11; 7: CD002991

    PubMed  Google Scholar 

  69. Andréjak C, Nielsen R, Thomsen VO, et al. Chronic respiratory disease, inhaled corticosteroids and risk of nontubercolous mycobacteriosis. Thorax 2012 July 10

    Google Scholar 

  70. Rastogi D, Pelter MA, Deamer RL. Evaluations of hospitalizations associated with thiazide-associated hyponatremia. J Clin Hypertens (Greenwich) 2012 Mar; 14 (3): 158–64

    Article  CAS  Google Scholar 

  71. Huang AR, Mallet L, Rochefort CM, et al. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 2012 May 1; 29 (5): 359–76

    Article  PubMed  CAS  Google Scholar 

  72. Loboz KK, Shenfield GM. Drug combinations and impaired renal function — the “triple whammy”. Br J Clin Pharmacol 2005 Feb; 59 (2): 239–43

    Article  PubMed  CAS  Google Scholar 

  73. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 Dec 17; 106 (25): 3143–421

    Google Scholar 

  74. Thomas JE, Tershakovec AM, Jones-Burton C, et al. Lipid lowering for secondary prevention of cardiovascular disease in older adults. Drugs Aging 2010 Dec 1; 27 (12): 959–72

    Article  PubMed  CAS  Google Scholar 

  75. Pratt N, Roughead EE, Ryan P, et al. Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veterans populations: a retrospective cohort study. Drugs Aging 2010 Jan 1; 27 (1): 63–71

    Article  PubMed  CAS  Google Scholar 

  76. Laharie D, Droz-Perroteau C, Bénichou J, et al. Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol 2010 Mar; 69 (3): 295–302

    Article  PubMed  Google Scholar 

  77. Schneider V, Lévesque LE, Zhang B, et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol 2006 Nov 1; 164 (9): 881–9

    Article  PubMed  Google Scholar 

  78. Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 2009 Nov; 8 (6): 669–81

    Article  PubMed  CAS  Google Scholar 

  79. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009 Aug; 57 (8): 1331–46

    Article  Google Scholar 

  80. Larson AM, Polson J, Fontana RJ, et al., Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: result of a United States multicenter, prospective study. Hepatology 2005 Dec; 42 (6): 1364–72

    Article  PubMed  CAS  Google Scholar 

  81. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 2008 Mar; 4 (1): 2–6

    Article  PubMed  Google Scholar 

  82. Food and Drugs Administration, HHS. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter humane use; final monograph. Final rule. Fed Regist 2009 Apr 29; 74 (81): 19385–409

    Google Scholar 

  83. Hornsby LB, Whitley HP, Hester EK, et al. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. J Am Pharm Assoc (2003) 2010 Jul–Aug; 50 (4): 485–9

    Article  Google Scholar 

  84. Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008 Jul–Aug; 8 (4): 287–313

    Article  PubMed  Google Scholar 

  85. Fine PG. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med 2012 Apr; 13 Suppl. 2: S57–66

    Article  PubMed  Google Scholar 

  86. Meulendijks D, Mannesse CK, Jansen PA, et al. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010 Feb 1; 33 (2): 101–14

    Article  PubMed  CAS  Google Scholar 

  87. Mannesse CK, van Puijenbroek EP, Jansen PA, et al. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case—control study in VigiBase. Drug Saf 2010 Jul; 33 (7): 569–78

    Article  PubMed  CAS  Google Scholar 

  88. Hill KD, Wee R. Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging 2012 Jan 1; 29 (1): 15–30

    Article  PubMed  Google Scholar 

  89. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999 Jan; 47 (1): 30–9

    PubMed  CAS  Google Scholar 

  90. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication class in falls in elderly persons [published erratum in Arch Intern Med 2010 Mar 8; 170 (5): 477]. Arch Intern Med 2009 Nov 23; 169 (21): 1952–60

    Article  PubMed  Google Scholar 

  91. Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010 Nov; 26 (4): 583–605

    Article  PubMed  Google Scholar 

  92. Bloch F, Thibaud M, Dugué B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011 Mar; 23 (2): 329–46

    Article  PubMed  Google Scholar 

  93. Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011 May; 59 (5): 875–80

    Article  PubMed  Google Scholar 

  94. Lönnroos E, Gnjidic D, Hilmer SN, et al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging 2012 May 1; 29 6(5): 395–404

    Article  Google Scholar 

  95. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother 2006 Sep; 40 (9): 1618–22

    Article  PubMed  CAS  Google Scholar 

  96. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25 (6): 501–19

    Article  PubMed  CAS  Google Scholar 

  97. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: metaanalysis of randomized placebo-controlled trials. JAMA 2005 Oct 19; 294 (15): 1934–43

    Article  PubMed  CAS  Google Scholar 

  98. Sacchetti E, Turrina C, Valsecchi P. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review. Drug Saf 2010 Apr 1; 33 (4): 273–88

    Article  PubMed  CAS  Google Scholar 

  99. Kuehn BM. FDA: Antipsychotics risky for elderly. JAMA 2008 Jul 23; 300 (4): 379–80

    Article  PubMed  CAS  Google Scholar 

  100. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005 Dec 1; 353 (22): 2335–41

    Article  PubMed  CAS  Google Scholar 

  101. Laredo L, Vargas E, Blasco AJ, et al. Risk of cerebrovascular accident associated with use of antipsychotics: population-based case—control study. J Am Geriatr Soc 2011 Jul; 59 (7): 1182–7

    Article  PubMed  Google Scholar 

  102. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 2005 Feb 26; 330 (7489): 445

    Article  PubMed  Google Scholar 

  103. Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005 Mar 28; 165 (6): 696–701

    Article  PubMed  Google Scholar 

  104. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death [published erratumin N Engl J Med 2009 Oct 29; 361 (18): 1814]. N Engl J Med 2009 Jan 15; 360 (3): 225–35

    Article  PubMed  CAS  Google Scholar 

  105. Pariente A, Fourrier-Réglat A, Ducruet T, et al. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med 2012 Apr 23; 172 (8): 648–53

    Article  PubMed  Google Scholar 

  106. Kleijer BC, Koek HL, van Marum RJ, et al. Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study. Heart 2012 Aug; 98 (15): 1166–71

    Article  PubMed  Google Scholar 

  107. Brauer R, Douglas I, Smeeth L. The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. Br J Clin Pharmacol 2011 Dec; 72 (6): 871–8

    Article  PubMed  Google Scholar 

  108. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): longterm follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8 (2): 151–7

    Article  PubMed  CAS  Google Scholar 

  109. Knol W, van Marum RJ, Jansen PA, et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008 Apr; 58 (4): 661–6

    Article  Google Scholar 

  110. Gau JT, Acharya U, Khan S, et al. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr 2010 Jul 6; 10: 45

    Article  PubMed  Google Scholar 

  111. Gill SS, Anderson GM, Fischer HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med 2009 May 11; 169 (9): 867–73

    Article  PubMed  Google Scholar 

  112. Park-Wyllie LY, Mamdani MM, Li P, et al. Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. PLoS Med 2009 Sep; 6 (9): e1000157

    Article  PubMed  CAS  Google Scholar 

  113. Kim DH, Brown RT, Ding EL, et al. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc 2011 Jun; 59 (6): 1019–31

    Article  PubMed  Google Scholar 

  114. Juurlink DN, Mamdani MM, Kopp A, et al. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc 2004 May; 52 (5): 794–8

    Article  PubMed  Google Scholar 

  115. McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012 Feb 25; 379 (9817): 721–8

    Article  PubMed  CAS  Google Scholar 

  116. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem 2010; 17 (6): 571–84

    Article  PubMed  CAS  Google Scholar 

  117. Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med 2012 May; 28 (2): 273–86

    Article  PubMed  Google Scholar 

  118. Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging 2009; 26 (7): 595–606

    Article  PubMed  Google Scholar 

  119. Leendertse AJ, van Dijk EA, De Smet PA, et al. Contribution of renal impairment to potentially preventable medication-related hospital admissions. Ann Pharmacother 2012 May; 46 (5): 625–33

    Article  PubMed  Google Scholar 

  120. Rodenburg EM, Stricker BH, Visser LE. Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. Br J Clin Pharmacol 2011 Jan; 71 (1): 95–104

    Article  PubMed  Google Scholar 

  121. Mesika Y, Lee BC, Tsimerman Y, et al. Using pharmacogenetics knowledge to increase accuracy of alerts for adverse drug events. Stud Health Technol Inform 2011; 169: 569–73

    PubMed  Google Scholar 

  122. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007 Dec; 5 (4): 345–51

    Article  PubMed  Google Scholar 

  123. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007 Feb; 63 (2): 187–95

    Article  PubMed  Google Scholar 

  124. Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012 May 16; 5: CD008165

    PubMed  Google Scholar 

  125. Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009 Jan 7; 338: a2752

    Article  PubMed  Google Scholar 

  126. Hines LE, Murphy JE. Potentially harmful drug—drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011 Dec; 9 (6): 364–77

    Article  PubMed  CAS  Google Scholar 

  127. Hanlon JT, Sloane RJ, Pieper CF, et al. Association of adverse drug reactions with drug—drug and drug—disease interactions in frail older outpatients. Age Ageing 2011 Mar; 40 (2): 274–7

    Article  PubMed  Google Scholar 

  128. Roughead EE, Kalisch LM, Barratt JD, et al. Prevalence of potentially hazardous drug interactions amongst Australian veterans. Br J Clin Pharmacol 2010 Aug; 70 (2): 252–7

    Article  PubMed  Google Scholar 

  129. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 2012 May; 28 (2): 173–86

    Article  PubMed  Google Scholar 

  130. Wierenga PC, Buurman BM, Parlevliet JL, et al. Association between acute geriatric syndromes and medication-related hospital admissions. Drugs Aging 2012 Aug 1; 29 (8): 691–9

    PubMed  Google Scholar 

  131. Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010 Sep; 58 (9): 1791–6

    Article  PubMed  Google Scholar 

  132. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 2011 Mar 28; 171 (6): 550–6

    Article  PubMed  Google Scholar 

  133. O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008 Mar; 37 (2): 138–41

    Article  PubMed  Google Scholar 

  134. Guaraldo L, Cano FG, Damasceno GS, et al. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr 2011 Nov 30; 11:79

    Article  PubMed  Google Scholar 

  135. Corsonello A, Pranno L, Garasto S, et al. Potentially inappropriate medication in elderly hospitalized patients. Drugs Aging 2009 Dec; 26 Suppl. 1: 31–9

    Article  PubMed  Google Scholar 

  136. Ruggiero C, Dell’Aquila G, Gasperini B, et al., ULISSE Study Group. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging 2010 Sep 1; 27 (9): 747–58

    Article  PubMed  Google Scholar 

  137. Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005 Mar 16; 293 (11): 1348–58

    Article  PubMed  Google Scholar 

  138. Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007 Feb; 63 (2): 177–86

    Article  PubMed  Google Scholar 

  139. Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging 2010 May; 27 (5): 407–15

    Article  PubMed  Google Scholar 

  140. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007 Jul 14; 370 (9582): 173–84

    Article  PubMed  Google Scholar 

  141. O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging 2012 Jun 1; 29 (6): 437–52

    Article  PubMed  Google Scholar 

  142. Hamilton HJ, Gallagher PF, O’Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009 Jan 28; 9: 5

    Article  PubMed  Google Scholar 

  143. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151 (9): 1825–32

    Article  PubMed  CAS  Google Scholar 

  144. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997 Jul 28; 157 (14): 1531–6

    Article  PubMed  CAS  Google Scholar 

  145. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163 (22): 2716–24

    Article  PubMed  Google Scholar 

  146. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012 Apr; 60 (4): 616–31

    Article  Google Scholar 

  147. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46 (2): 72–83

    PubMed  CAS  Google Scholar 

  148. Gallagher P, Baeyens JP, Topinkova E, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009 Sep; 38 (5): 603–6

    Article  PubMed  Google Scholar 

  149. Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008 Nov; 37 (6): 673–9

    Article  PubMed  Google Scholar 

  150. Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010 Jun; 44 (6): 957–63

    Article  PubMed  Google Scholar 

  151. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011 Jun 13; 171 (11): 1013–19

    Article  PubMed  Google Scholar 

  152. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011 Jul; 89 (6): 845–54

    Article  PubMed  CAS  Google Scholar 

  153. Steinman MA, Handler SM, Gurwitz JH, et al. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011 Aug; 59 (8): 1513–20

    Article  PubMed  Google Scholar 

  154. Thomsen LA, Winterstein AG, Søndergaard B, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007 Sep; 41 (9): 1411–26

    Article  PubMed  Google Scholar 

  155. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003 Mar 5; 289 (9): 1107–16

    Article  PubMed  Google Scholar 

  156. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003 Apr 17; 348 (16): 1556–64

    Article  PubMed  Google Scholar 

  157. Budnitz DS, Shehab N, Kegler SR, et al. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007 Dec 4; 147 (11): 755–65

    PubMed  Google Scholar 

  158. Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med 2005 Jan 24; 165 (2): 234–40

    Article  PubMed  Google Scholar 

  159. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997 Oct 25; 315 (7115): 1096–9

    Article  PubMed  CAS  Google Scholar 

  160. Leape LL, Lawthers AG, Brennan TA, et al. Preventing medical injury. QRB Qual Rev Bul 1993 May; 19 (5): 144–9

    CAS  Google Scholar 

  161. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med 2010 May 6; 362 (18): 1698–707

    Article  PubMed  CAS  Google Scholar 

  162. Barker KN, Flynn EA, Pepper GA, et al. Medication errors observed in 36 health care facilities. Arch Intern Med 2002 Sep 9; 162 6(16): 1897–903

    Article  Google Scholar 

  163. Cassidy N, Duggan E, Williams DJ, et al. The epidemiology and type of medication errors reported to the National Poisons Information Centre of Ireland. Clin Toxicol (Phila) 2011 Jul; 49 (6): 485–91

    Article  Google Scholar 

  164. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008 Apr 16; 2: CD000011

    PubMed  Google Scholar 

  165. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002 Sep; 36 (9): 1331–6

    Article  PubMed  Google Scholar 

  166. Marcum ZA, Pugh MJ, Amuan ME, et al. Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans. J Gerontol A Biol Sci Med Sci 2012 Aug; 67 (8): 867–74

    Article  PubMed  Google Scholar 

  167. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992 Jan; 33 (1): 61–8

    Article  PubMed  CAS  Google Scholar 

  168. Kaiser RM, Schmader KE, Pieper CF, et al. Therapeutic failure-related hospitalizations in the frail elderly. Drugs Aging 2006; 23 (7): 579–86

    Article  PubMed  Google Scholar 

  169. Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med 2012 May; 28 (2): 287–300

    Article  PubMed  Google Scholar 

  170. Topinková E, Baeyens JP, Michel JP, et al. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012 Jun 1; 29 (6): 477–94

    Article  PubMed  Google Scholar 

  171. Jylhä V, Saranto K, Bates DW. Preventable adverse drug events and their causes and contributing factors: the analysis of register data. Int J Qual Health Care 2011 Apr; 23 (2): 187–97

    Article  PubMed  Google Scholar 

  172. Committee on Identifying and Preventing Medication Errors. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, editors. Preventing Medication Errors: Quality Chasm Series. The national Academies Press 2007. Available from URL: http://www.nap.edu/catalog.php?record_id=11623. [Accessed 2012 October 1]

  173. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012 Jun 1; 29 (6): 453–62

    Article  PubMed  Google Scholar 

  174. Fitzgerald RJ. Medication errors: the importance of an accurate drug history. Br J Clin Pharmacol 2009 Jun; 67 (6): 671–5

    Article  PubMed  Google Scholar 

  175. Shenfield GM, Robb T, Duguid M. Recording previous adverse drug reactions — a gap in the system. Br J Clin Pharmacol 2001 Jun; 51 (6): 623–6

    Article  PubMed  CAS  Google Scholar 

  176. Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009 Mar; 104 (3): 728–38

    Article  PubMed  Google Scholar 

  177. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166 (6): 605–9

    Article  PubMed  Google Scholar 

  178. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26 (12): 1013–28

    Article  PubMed  Google Scholar 

  179. Clyne B, Bradley MC, Hughes C, et al. Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence. Clin Geriatr Med 2012 May; 28 (2): 301–22

    Article  PubMed  Google Scholar 

  180. Royal S, Smeaton L, Avery AJ, et al. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006 Feb; 15 (1): 23–31

    Article  PubMed  CAS  Google Scholar 

  181. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004 Mar 15; 116 (6): 394–401

    Article  PubMed  Google Scholar 

  182. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998 Oct 21; 280 (15): 1311–16

    Article  PubMed  CAS  Google Scholar 

  183. Leendertse AJ, de Koning FH, Goudswaard AN, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Serv Res 2011 Jan 7; 11: 4

    Article  PubMed  Google Scholar 

  184. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25 (12): 1021–31

    Article  PubMed  Google Scholar 

  185. Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012 May; 28 (2): 237–53

    Article  PubMed  Google Scholar 

  186. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011 Feb; 9 (1): 11–23

    Article  PubMed  Google Scholar 

  187. Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomized controlled trial of case conferencing. Age Ageing 2004 Nov; 33 (6): 612–17

    Article  PubMed  Google Scholar 

  188. Saltvedt I, Spigset O, Ruths S, et al. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol 2005 Dec; 61 (12): 921–8

    Article  PubMed  Google Scholar 

  189. Mangoni AA. Predicting and detecting adverse drug reactions in old age: challenges and opportunities. Expert Opin Drug Metab Toxicol 2012 May; 8 (5): 527–30

    Article  PubMed  CAS  Google Scholar 

  190. Greenwald JL, Halasyamani L, Greene J, et al. Making inpatient medication reconciliation patient centered, clinically relevant and implementable: a consensus statement on key principles and necessary first steps. J Hosp Med 2010 Oct; 5 (8): 477–85

    Article  PubMed  Google Scholar 

  191. Schnipper JL, Hamann C, Ndumele CD, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a clusterrandomized trial. Arch Intern Med 2009 Apr 27; 169 (8): 771–80

    Article  PubMed  Google Scholar 

  192. Boockvar KS, Blum S, Kugler A, et al. Effect of admission medication reconciliation on adverse drug events from admission medication changes. Arch Intern Med 2011 May 9; 171 (9): 860–1

    Article  PubMed  Google Scholar 

  193. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010 Jul 12; 170 (13): 1142–8

    Article  PubMed  Google Scholar 

  194. O’Connor MN, Gallagher P, Byrne S, et al. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing 2012 Nov; 41 (6): 771–6

    Article  PubMed  Google Scholar 

  195. Kriplani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007 Mar 26; 167 6(6): 540–50

    Article  Google Scholar 

  196. Schlenk EA, Bernardo LM, Organist LA, et al. Optimizing Medication Adherence in Older Patients: A Systematic Review. J Clin Outcomes Manag 2008 Dec 1; 15 (12): 595–606

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Cherubini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvi, F., Marchetti, A., D’Angelo, F. et al. Adverse Drug Events as a Cause of Hospitalization in Older Adults. Drug Saf 35 (Suppl 1), 29–45 (2012). https://doi.org/10.1007/BF03319101

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03319101

Keywords

Navigation